ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,541Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 387

$641K Total Retail Price of All Prescriptions

Rank: 86 out of 387

410 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

5% of this provider’s 7,070 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 633 368 S3 1 1
CARISOPRODOL 310 97 R 2 53
OMEPRAZOLE 289 144 3 4
FUROSEMIDE 286 193 4 7
LEVOTHYROXINE SODIUM 267 195 5 2
GABAPENTIN 228 112 6 10
SIMVASTATIN 227 159 7 5
LISINOPRIL 213 140 8 3
HYDROCHLOROTHIAZIDE 207 160 9 12
ZOLPIDEM TARTRATE 188 98 10 16
PRAVASTATIN SODIUM 185 130 11 15
METFORMIN HCL 180 128 12 8
MELOXICAM 179 121 13 22
SERTRALINE HCL 179 112 13 23
METOPROLOL TARTRATE 171 133 15 11
NEXIUM 161 80 16 26
RISPERIDONE 157 67 17 70
TRAMADOL HCL 156 78 18 14
ATORVASTATIN CALCIUM 142 91 19 13
AMLODIPINE BESYLATE 142 98 19 6
METOPROLOL SUCCINATE 131 87 21 18
POTASSIUM CHLORIDE 130 113 22 9
AMITRIPTYLINE HCL 126 41 R 23 62
PROAIR HFA 125 43 24 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 122 64 25 90
CARVEDILOL 115 68 26 21
ATENOLOL 111 64 27 20
FAMOTIDINE 104 67 28 78
IBUPROFEN 97 61 29 85
ROPINIROLE HCL 93 70 30 91
RANITIDINE HCL 93 76 30 45
HYDROXYZINE HCL 93 70 R 30 210
GLYBURIDE 89 66 R 33 58
ALLOPURINOL 87 50 34 28
FLUOXETINE HCL 87 47 34 46
NAPROXEN 86 38 36 89
SPIRONOLACTONE 83 61 37 67
TRAZODONE HCL 81 18 38 37
CITALOPRAM HBR 80 48 39 19
AMLODIPINE BESYLATE-BENAZEPRIL 74 60 40 54
DIGOXIN 69 48 41 40
ADVAIR DISKUS 68 34 42 41
MIRTAZAPINE 67 46 43 64
RAMIPRIL 64 52 44 119
LYRICA 63 51 45 66
PAROXETINE HCL 62 21 46 52
ENDOCET 62 38 S2 46 147
CARBIDOPA-LEVODOPA 62 57 46 104
DONEPEZIL HCL 58 58 49 27
DOXAZOSIN MESYLATE 58 40 49 75
PHENYTOIN SODIUM EXTENDED 57 26 51 107
CYMBALTA 57 21 51 44
ENALAPRIL MALEATE 56 41 53 69
CAPTOPRIL 52 41 54 237
ACETAMINOPHEN-CODEINE 51 49 S3 55 155
LANTUS SOLOSTAR 51 31 55 102
CLOPIDOGREL 50 42 57 25
CYCLOBENZAPRINE HCL 50 17 R 57 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.